Pivotal trials of the anticoagulant Arixtra submitted to FDA by GlaxoSmithKline PHILADELPHIA, PA, October 2, 2006 – GlaxoSmithKline plc [LSE and NYSE: GSK] announced today that the supplemental new ...

Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today ...

To earn CME related to this news article, click here. January 21, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of the potential for ...

June 9, 2005 — The U.S. Food and Drug Administration (FDA) has approved a capsule formulation of paricalcitol for the prevention and treatment of secondary hyperparathyroidism in patients with stage ...

Mylan (Nasdaq: MYL) announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectual property rights relating to ...

The approval by US Food & Drug Administration (USFDA) is for multiple strengths of Fondaparinux Sodium injection of 2.5 mg/0.5 mL, 5 mg/0.4 mL, 7.5 mg/0.6 mL, and 10 mg/0.8 mL single-dose prefilled ...

HYDERABAD, India & BRISBANE, Australia--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final ...

Please provide your email address to receive an email when new articles are posted on . A 45-day course of rivaroxaban for the treatment of high-risk patients with superficial vein thrombosis did not ...

Drug firm Dr Reddy’s Laboratories said it has resolved all issues raised by a division of US health regulator over its promotional material for an anti-coagulant injection. On January 10, 2012, Office ...

Mylan Inc. ( MYL) is all set to acquire the U.S. commercialization, marketing and intellectual property rights to Arixtra injection from Aspen Global Incorporated for $225 million (initial payment).

BRISBANE, Australia--(BUSINESS WIRE)--Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection (the generic version of ...

New Delhi, Dec 27 (PTI) Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to ...